Plasma-Resectoscope for Non-Muscle Invasive Bladder Cancer (NMIBC)

This 26Fr resectoscope integrates three groundbreaking technologies:

1. Hybrid Plasma:Combines 2.45GHz microwave and bipolar plasma (patent pending)

2. Specimen Capture:Integrated retrieval net prevents tumor seeding

3. Margin Mapping:Real-time OCT imaging detects residual cancer cells

Performance Metrics

• Resection Speed: 3.2cm²/min (vs. 1.8cm²/min standard TURBT)

• Thermal Injury Depth: 0.05mm (histologically confirmed)

• Pathology Preservation: 98% specimen integrity for staging

Clinical Validation

• EMERGING Trial Data (n=467):

  • 94% RFS at 12 months vs. 76% conventional TURBT

  • 0% obturator nerve reflex incidents

Ordering Details

• Configurations: 30° and 70° lens options

• Compatibility: Storz IMAGE1 S 4K systems

• Regulatory: FDA PMA P210032, MDR compliant

Exhibition